Avalo Therapeutics AVTX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $16.11M-88.0% | $134.7M+1,685% | $7.55M-43.3% | $13.32M-75.7% | ||
| $82.48M— | $0— | —— | —— | ||
| $105.29M-24.2% | $138.89M+1,554% | $8.4M-48.9% | $16.42M-73.5% | ||
| $10.5M0.0% | $10.5M0.0% | $10.5M-27.1% | $14.41M0.0% | ||
| $116.46M-22.7% | $150.73M+618% | $20.99M-37.1% | $33.37M-58.4% | ||
| $137K-51.6% | $283K-36.5% | $446K-84.5% | $2.88M-14.5% | ||
| $12.94M+85.9% | $6.96M+50.7% | $4.62M-79.1% | $22.11M+11.2% | ||
| $33.41M+88.8% | $17.7M+29.3% | $13.69M-69.1% | $44.28M-22.5% | ||
| 200M+1,999,900% | 10K+900% | 1K— | 0-100% | ||
| -$448.52M-21.1% | -$370.26M-10.5% | -$335.13M-10.3% | -$303.82M-15.9% | ||
| $83.05M-37.6% | $133.03M+1,721% | $7.3M+167% | -$10.92M-147% | ||
| $116.46M-22.7% | $150.73M+618% | $20.99M-37.1% | $33.37M-58.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Avalo Therapeutics's total assets?
- Avalo Therapeutics (AVTX) holds $99.9M in total assets, down 27.9% year over year.
- How much debt does Avalo Therapeutics have?
- Avalo Therapeutics carries $328.0K in total debt against $68.3M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Avalo Therapeutics have?
- Avalo Therapeutics holds $25.3M in cash and equivalents.
- Can Avalo Therapeutics cover its short-term obligations?
- Its current ratio is 7.66 — current assets exceed current liabilities.
- Where does Avalo Therapeutics's balance sheet data come from?
- Every line is extracted from Avalo Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
